“Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, Apr. 2026, doi: 10.4084/MJHID.2026.044.